Daiwa Securities Group Inc. Has $392,000 Stock Position in Masimo Co. (NASDAQ:MASI)

Daiwa Securities Group Inc. lowered its stake in Masimo Co. (NASDAQ:MASIGet Rating) by 14.7% during the first quarter, Holdings Channel reports. The institutional investor owned 2,693 shares of the medical equipment provider’s stock after selling 465 shares during the period. Daiwa Securities Group Inc.’s holdings in Masimo were worth $392,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. grew its holdings in Masimo by 1.5% in the fourth quarter. BlackRock Inc. now owns 9,026,374 shares of the medical equipment provider’s stock worth $2,642,740,000 after purchasing an additional 133,072 shares during the period. State Street Corp grew its holdings in Masimo by 0.8% in the fourth quarter. State Street Corp now owns 1,703,730 shares of the medical equipment provider’s stock worth $498,818,000 after purchasing an additional 13,399 shares during the period. Invesco Ltd. grew its holdings in Masimo by 12.9% in the fourth quarter. Invesco Ltd. now owns 1,307,606 shares of the medical equipment provider’s stock worth $382,840,000 after purchasing an additional 149,083 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Masimo by 1.2% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 855,583 shares of the medical equipment provider’s stock worth $250,497,000 after purchasing an additional 9,847 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Masimo by 2.2% in the fourth quarter. Geode Capital Management LLC now owns 662,774 shares of the medical equipment provider’s stock worth $193,760,000 after purchasing an additional 13,952 shares during the period. Institutional investors own 92.03% of the company’s stock.

Masimo Price Performance

MASI opened at $138.92 on Monday. The company’s 50-day moving average is $135.35 and its 200 day moving average is $156.36. Masimo Co. has a fifty-two week low of $112.07 and a fifty-two week high of $305.21. The firm has a market capitalization of $7.71 billion, a P/E ratio of 35.90 and a beta of 0.98.

Masimo (NASDAQ:MASIGet Rating) last released its quarterly earnings results on Tuesday, May 3rd. The medical equipment provider reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. Masimo had a net margin of 17.91% and a return on equity of 15.46%. The company had revenue of $304.24 million for the quarter, compared to analyst estimates of $308.04 million. During the same period last year, the firm earned $0.90 earnings per share. The firm’s revenue was up 1.7% on a year-over-year basis. On average, equities research analysts expect that Masimo Co. will post 4.61 earnings per share for the current year.

Analyst Ratings Changes

MASI has been the topic of a number of recent research reports. Needham & Company LLC dropped their price objective on shares of Masimo from $205.00 to $163.00 in a research note on Wednesday, May 4th. Stifel Nicolaus dropped their price objective on shares of Masimo from $175.00 to $150.00 in a research note on Wednesday, May 4th. Wolfe Research initiated coverage on shares of Masimo in a research note on Tuesday, April 5th. They issued a “market perform” rating and a $160.00 price objective on the stock. Piper Sandler dropped their price objective on shares of Masimo from $160.00 to $130.00 in a research note on Wednesday, May 4th. Finally, StockNews.com raised shares of Masimo from a “hold” rating to a “buy” rating in a research note on Wednesday, July 13th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $179.60.

About Masimo

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Stories

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.